University of California San Francisco
Give to UCSF
New UCSF Robotic Pharmacy Aims to Improve Patient Safety
UCSF has opened an automated hospital pharmacy believed to be the nation’s most comprehensive facility using robotic technology and electronics to prepare and track medications with the goal of improving patient safety.
UCSF Collaborates with Zcube to Develop New Ways to Deliver Drugs
UCSF and Zcube have entered into a new agreement to license UCSF-developed microtechnology and support early research into new ways to deliver oral medications directly to a targeted site in the body.
Spotlight: Madalene Mandap
UCSF School of Pharmacy student Madalene Mandap, who co-chairs the LGBT Student Association, recently won the grand prize in a US Centers for Disease Control and Prevention’s video competition for best video combating the flu.
Cutting-Edge Interventional MRI System Transforms Brain Surgery for Parkinson's Patients
UCSF neurosurgeons and an MRI physicist have pioneered a faster, more accurate and less invasive surgical technique for treating patients with movement disorders, potentially changing the future of neurosurgery.
Chemicals in Environment Deserve Study for Possible Role in Fat Gain, Says Byers Award Recipient
Weight gain and environmental pollutants might be linked, an award-winning worm researcher suggests.
UCSF "fountain of youth" pill could restore aging immune system
UCSF researchers have identified an existing medication that restores key elements of the immune system that, when out of balance, lead to a steady decline in immunity and health as people age.
UCSF School of Pharmacy Appoints Ortiz de Montellano as Associate Dean of Research
Paul Ortiz de Montellano has been appointed associate dean of research in the UCSF School of Pharmacy, a key advisor to the dean on campus, national and international science opportunities issues and trends.
Arthritis drugs could help prevent memory loss after surgery
Anti-inflammatory drugs currently used to treat diseases such as rheumatoid arthritis may also help prevent cognitive decline after surgery, according to a new study led by researchers at UCSF and colleagues at Imperial College London.
Gallo Center researchers find potential new drug target for alcohol addiction
Rapamycin, an FDA-approved drug prescribed to prevent the rejection of transplanted organs, has been shown for the first time to decrease excessive alcohol consumption, binge drinking, and alcohol-seeking behavior in rodents.
UCSF Stem-Cell Based Neurological, Liver Therapy Strategies Advanced
UCSF scientists have received two grants from the California Institute for Regenerative Medicine to refine their human embryonic stem cell-based strategies for treating neurological diseases and liver failure.